We cannot exclude the possibility that in vitro culture conditions may impact LRRK2 activity following lysosomal damage, and additional studies are warranted to understand whether similar regulation occurs in glial cells from PD patient brains with evidence of lysosomal dysfunction. The gene discussed is LRRK2; the disease is Parkinson disease.